Full Press Release Details
SALT LAKE CITY, May 16, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced that it will participate in the following investor conferences:
H.C. Wainwright Global Investment Conference, May 24-26, 2022
Presentation Time: May 25, 2022, at 2 p.m. ET
Benchmark Healthcare House Call Virtual 1x1 Conference, June 2, 2022
JMP Securities Life Sciences Conference, June 15-16, 2022
Presentation Time: June 15, 2022, at 2 p.m. ET
Erica Fiorini, Ph.D., or David Schull
Managing Director, Westwicke